How does genetic modification address immune rejection in pig organs?

Question

Accepted Answer

Genetic Modification Enhances Pig Organ Viability for Human Transplants by Mitigating Immune Rejection

A recent surgical experiment involving a genetically modified pig kidney attached to a brain-dead patient demonstrated the organ's ability to function and remove waste, a critical step in advancing xenotransplantation. The genetic modification specifically targeted a gene responsible for producing a sugar that would otherwise provoke a severe immune response, leading to rapid organ rejection in humans. This procedure, performed by Revivicor, a subsidiary of United Therapeutics, represents a significant development in overcoming a primary barrier to cross-species organ donation.
Knocking Out the Gene for Immune Triggers

The donor pig underwent a precise genetic editing process designed to deactivate a specific gene. This gene's normal function is to produce a type of sugar that is recognized as foreign by the human immune system. In a standard xenotransplantation scenario without this modification, the presence of this sugar would immediately trigger a strong immune attack, resulting in hyperacute rejection of the transplanted organ. By "knocking out" this gene, the pig's cells no longer produce this problematic sugar, thereby reducing the likelihood of immediate immune-mediated rejection.
Reducing Immune System Activation

The absence of the targeted sugar significantly diminishes the activation of the human immune system against the pig organ. Normally, human immune cells, particularly antibodies, would swiftly identify and attack the foreign sugar molecules on the pig organ's surface. This aggressive immune response leads to rapid damage and failure of the transplanted organ. The genetic modification, by eliminating the production of this specific sugar, effectively makes the pig organ less visible or less offensive to the recipient's immune defenses, creating a more compatible environment for the organ to function.
Advancing Xenotransplantation Research

This approach is a crucial element in the broader field of xenotransplantation, which aims to address the critical shortage of donor organs for human recipients. While pig heart valves and skin are already used in human medicine, the transplantation of whole organs like kidneys has been historically hindered by intense immune rejection. The success in modifying the pig's genetic makeup to prevent the production of a key immune trigger, as demonstrated in this experiment, offers a promising pathway toward making pig organs a viable option for saving human lives.

Reading history

Hide →

This history is cleared when the page is closed.

How does genetic modification address immune rejection in pig organs?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends